Epidemiology of Hepatitis A and Hepatitis E Infection and Their Determinants in Adult Chinese Community in Hong Kong

Journal of Medical Virology

Volumn 72, Issue 4, 2004, Pages 538-544

  Wong, K H ^a,d   Liu, Y M ^b   Ng, P S P ^b   Young, B W Y ^c   Lee, S S ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOSPITAL AUTHORITY   (Hong Kong)

^d DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Asia; Seroprevalence; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; CHINESE; COHORT ANALYSIS; COMMUNITY; EPIDEMIOLOGICAL DATA; EVALUATION; FEMALE; FUTUROLOGY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HONG KONG; HUMAN; INFECTION CONTROL; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TELEPHONE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS, HUMAN; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HONG KONG; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROBABILITY; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS A VIRUS; HEPATITIS E VIRUS;

EID: 1542304546     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20040     Document Type: Article

References (30)

1. Averhoff F, Shapiro CN, Bell BP, et al. 2001. Control of hepatitis A through routine vaccination of children. JAMA 286:2968-2973.
2. Bryan JP, Nelson M. 1994. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Arch Intern Med 154:663-668.
3. Chau TN, Lai ST, Lai JY, Yuen H. 1997. Acute viral hepatitis in Hong Kong: A study of recent incidences. HKMJ 3:261-266.
4. Chau TN, Tse CWS, Ng TK, Lai JY, Lai ST. 1998. The role of hepatitis E virus in acute non-A non-B non-C hepatitis in Hong Kong. 2nd Annual Scientific Meeting, Hong Kong Society for Infectious Diseases.
5. Chin KP, Lok AS, Wong LS, Lai CL, Wu PC. 1991. Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 34:191-193.
6. Favorov MO, Fields HA, Purdy MA, et al. 1992. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 36:246-250.
7. Frosner GG, Papaevangelou G, Butler R, et al. 1979. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol 1979: 63-69.
8. Goldsmith R, Yarbough PO, Reyes GR, et al. 1992. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 339:328-331.
9. Gust ID. 1984. The epidemiology of viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. Orlando: Grune & Stratton. pp 415-421.
10. Gust ID, Lehmann NI, Lucas CR. 1978. Relationship between prevalence of antibody to hepatitis A antigen and age: A cohort effect? J Infect Dis 138:425-426.
11. Hong Kong SAR Department of Health. 1997. Reporting of viral hepatitis diseases. In: Surveillance of viral hepatitis in Hong Kong-1997 Update Report. pp 6-9.
12. Hong Kong SAR Department of Health. 2002a. No. of notifications for notifiable infectious diseases in 2002. Available from: URL: http:// www.info.gov.hk/dh/diseases/index.htm (accessed on 29 April, 2003).
13. Hong Kong SAR Department of Health. 2002b. Acute viral hepatitis. In: Surveillance of viral hepatitis in Hong Kong-2001 Update Report. pp 10-13.
14. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. 1985. Changing seroepidemiology of hepatitis A virus infection in Taiwan. J Med Virol 17:297-301.
15. Khuroo MS, Teli MR, Skidmore S, et al. 1981. Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252-255.
16. Kremastinou J, Kalapothaki V, Trichopoulos D. 1984. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 120:703-706.
17. Lee A, Cheng F, Lau L, Lo A, Fabb WE. 1999. Should adolescents be vaccinated against hepatitis A: The Hong Kong experience. Vaccine 18:941-946.
18. Lo YC, Lee SS, Wong KH, Lim WL. 1996. Inactivated hepatitis A vaccine in healthy Chinese adults. J Int Med 239:173-176.
19. Lok AS, Kwan WK, Moeckli R, et al. 1992. Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays. Lancet 340:1205-1208.
20. Murhekar MV, Sehgal SC, Murhekar KM, Padbhidri SP, Chitambar SD, Arankalle VA. 2002. Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10-year period 1989-99. J Viral Hepat 9:315-321.
21. Reyes GR, Purdy MA, Kim JP, et al. 1990. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247:1335-1339.
22. Syed SA, Sarwari AR, Smego RA, Hamid S, Nissa T. 2003. Does infection with hepatitis A virus provide protection against hepatitis E virus? Med Hypotheses 60:337-339.
23. Tsang CW, Chan CL. 1987. Epidemiology of viral hepatitis in Hong Kong. In: New trends in peptic ulcer and chronic hepatitis-Part II. Chronic hepatitis. Excerpta Medica. pp 43-50.
24. Weiland O, Berg JV, Bottiger M, Lundbergh P. 1980. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community. Scand J Infect Dis 12:171-174.
25. Werzberger A, Mensch B, Kuter B, et al. 1992. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 327:453-457.
26. Werzberger A, Kuter B, Nalin D. 1998. Six years' follow-up after hepatitis A vaccination. N Engl J Med 338:1160.
27. Westblom TU, Gudipati S, DeRousse C, Midkiff BR, Belshe RB. 1994. Safety and immunogenicity of an inactivated hepatitis A vaccine: Effect of dose and vaccination schedule. J Infect Dis 165:996-1001.
28. Wiens BL, Bohidar NR, Pigeon JG, et al. 1996. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA. J Med Virol 49:235-241.
29. Wong DC, Purcell RH, Sreenivasan MA, et al. 1980. Epidemic and endemic hepatitis in India: Evidence for a non-A, non-B hepatitis etiology. Lancet 2:876-879.
30. World Health Organisation. Hepatitis A vaccines. 2000. WHO position paper. Weekly Epidemiological Record 5:38-43.